Read More

WEGE Secures Project to Construct Coordinating Ministry for Maritime and Investment Affairs Office Complex at IKN

JAKARTA, Feb 2, 2023 - (ACN Newswire via SEAPRWire.com) - PT Wijaya Karya Bangunan Gedung Tbk (WEGE) has secured another project at the new capital city (Ibu Kota Negara, IKN) in East Kalimantan to construct the office complex for the Coordinating Ministry for Maritime and Investment Affairs (Kementerian Koordinator Kemaritiman dan Investasi, Kemenkomarves). The project was valued at Rp745 billion. WEGE has previously secured a project to construct modular buildings to house construction workers at IKN, and its progress has reached 94%.A highlight of the eight storey Kemenkomarves office is it features integrated Smart and Green Building concept.Another highlight is that the construction of the Kemenkomarves Office will implement Building Information Modelling (BIM) technology. The Kemenkomarves Office is located at Sepaku, Penajam Paser Utara and will not be far from the IKN Presidential Office.WEGE's scope of work in this project is design-build construction with a completion period of 660 working days. The Kemenkomarves office complex will cover an area of 24,274 square metres.WEGE Carries Out Groundbreaking of BMKG State College that Applies Smart and Green Building ConceptWEGE...

Read More

China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate

HONG KONG, Jan 10, 2023 - (ACN Newswire via SEAPRWire.com) - China Biotech Services Holdings Limited (the "Group"; stock code: 8037. HK) has announced that its subsidiary, Asia Molecular Diagnostics Laboratory (AMDL), has been nominated as the Top Clinical Laboratory Services Company in APAC 2022 and has received the College of American Pathologists (CAP) Accreditation Certificate for providing next-generation sequencing (NGS) Oncology clinical testing services. With world-leading NGS-based clinical testing products and services for oncologists and a high-standard molecular-level clinical laboratory, and as the sole distributor of Pillar Biosciences products in Asia, it's no surprise that AMDL has been named one of the industry's Top Clinical Laboratory Services Companies in APAC 2022 by Life Sciences Review. In addition, AMDL has recently received the Accreditation Certificate from CAP, which is recognized as one of the industry's leaders in medical laboratory quality assurance. It has developed detailed checklists for all aspects of clinical laboratory disciplines and has strict requirements for laboratory quality standards. AMDL obtaining the authoritative certification from CAP...

Read More

analytica Vietnam exhibition returns to reunite the industry after its 4 years hiatus

HO CHI MINH CITY, VIETNAM, Oct 11, 2022 - (ACN Newswire via SEAPRWire.com) - analytica Vietnam announces its return on 19-21 April 2023 to reunite the diagnostics laboratory industry in Southeast Asia after 4 years. It is part of the world's leading series of analytica exhibitions which is headlined by the world's largest show for this sector in Munich. The upcoming seventh edition of the trade fair for analysis, laboratory technology and biotechnology will be held at the Saigon Exhibition and Convention Center (SECC) in Ho Chi Minh City, Vietnam. Since its launch in 2009, analytica Vietnam has become the industry's most vital trade fair in the growing laboratory market in SEA. 2023 will be the first largest face-to-face reunion of the industry to resume its extensive conference program alongside supporting side events to accompany the exhibition. Companies who wish to exhibit can begin registration now for analytica Vietnam and rejoin industry experts - Analytik Jena, Merck, Metrohm, Mettler Toledo, Shimadzu and Water -- at the exhibition next spring.The largely expanding Vietnamese market for analysis, biotechnology and laboratory technology is displayed by the high demand for ex...

Read More

90 jobs to be added with expansion of Labcorp facility in S’pore, as biomedical sector continues to grow

SINGAPORE - Around 90 additional research and engineering jobs will be created in the biomedical sector with the setting up of a new bioanalytical laboratory facility by leading contract research organisation Labcorp, and the expansion of its existing central laboratory here. The combined facility in Jurong East, which is the first of its kind in South-east Asia, "will add cutting-edge capabilities to our thriving biomedical ecosystem" and "make us an even more compelling regional biomedical hub, help us attract more leading-edge investments in the sector", said Trade and Industry Minister Gan Kim Yong on Wednesday (Nov 10) at the facility's launch. "In particular, Labcorp's new Good Laboratory Practice and Good Clinical Practice-compliant bioanalysis and immunochemistry platforms will provide bioanalytical testing services that are critical to early-stage development of biologics and vaccines in Singapore," noted Mr Gan. He said that job opportunities that come with the expansion include those in the healthcare sector, such as nursing coordinators to facilitate decentralised clinical trials, as well as data engineers to develop artificial intelligence technologies to assist in dia...

Read More

$90m to be spent on Singapore’s first top-level biosafety lab, to be operational by 2025

SINGAPORE - Singapore will get its first highest-level biosafety containment lab ready by 2025 - the first such facility in South-east Asia - to prepare for the next big pandemic or biological threat, said Defence Minister Ng Eng Hen on Monday (March 1). Some $90 million will be spent to upgrade the capabilities of the national defence research agency DSO National Laboratories to biosafety level 4 (BSL-4), the topmost level of biosafety precautions globally, said Dr Ng during the debate over the Ministry of Defence's (Mindef) budget in Parliament. Viruses are classified into Risk Groups 1 to 4, according to their transmissibility and lethality. Current facilities within DSO National Laboratories can safely handle Risk Group 3 viruses like Sars (severe acute respiratory syndrome) and Covid-19, said Mindef. "Many developed countries already have labs with the highest biosafety level - BSL-4 - built many years ago. Since 2015, countries in Asia like China, Japan and Korea have also built such BSL-4 labs. In Asean, there are none," said Dr Ng. Some other BSL-4 laboratories around the world include the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia, the Rober...